SUBSCRIBE
SUBSCRIBE
News   Drug Development

Momenta Pharmaceuticals, Inc. (Jobs) Sees Longer US Review for Generic Lovenox

June 28, 2007 | 
1 min read
NEW YORK, June 28 (Reuters) - Momenta Pharmaceuticals Inc. said on Thursday a U.S. review of its application to sell a generic version of Sanofi-Aventis' big-selling Lovenox blood-thinner is taking longer than it previously projected.
Clinical research Postmarket research
MORE ON THIS TOPIC
vector illustration arrows miss the target board, concept of lost in focus, failure, fail, mistake
Clinical research
BMS’ Anemia Drug Reblozyl Flunks Phase III Myelofibrosis Trial
July 18, 2025
 · 
2 min read
 · 
Tristan Manalac
A person and a group of people are separated by a yellow line. Establishing contact. Distrust. Quarantine. Distance with strangers. Barrier to understanding, difficult integration. Rejection, refusal.
Cancer
GSK’s Blenrep Loses Adcomm Vote, Further Clouding Comeback Bid
July 18, 2025
 · 
2 min read
 · 
Tristan Manalac
Courtesy of Sarepta Therapeutics
Duchenne muscular dystrophy
Sarepta Reports a Third Gene-Therapy Related Patient Death
July 18, 2025
 · 
2 min read
 · 
Tristan Manalac
IN PARTNERSHIP WITH IQVIA
AI Is Taking Over Drug Safety Monitoring–But There’s One Thing It Can’t Replace
July 17, 2025
 · 
1 min read
 · 
Lori Ellis